ID
45657
Descrizione
Principal Investigator: Charles Kooperberg, PhD, Fred Hutchinson Cancer Research Center, Seattle, WA, USA MeSH: Stroke,Venous Thromboembolism https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001237 This is Whole Genome Sequencing data from the TOPMed participation of the Women's Health Initiative. Approximately 11,100 subjects were involved in this study: approximately 1,100 cases of VTE, 4,000 cases of ischemic stroke, 900 cases of hemorrhagic stroke, and 5,100 controls. Summary level phenotypes for the WHI Cohort study participants can be viewed at the top-level study page phs000200 WHI Cohort. Individual level phenotype data and molecular data for all WHI top-level study and substudies are available by requesting Authorized Access to the WHI Cohort study phs000200.
collegamento
Keywords
versioni (1)
- 21-03-23 21-03-23 - Simon Heim
Titolare del copyright
Charles Kooperberg, PhD, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Caricato su
21 maart 2023
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY 4.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
dbGaP phs001237 NHLBI TOPMed: Women's Health Initiative (WHI)
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- The subject consent data table includes subject IDs, consent group information, subject's sex, and subject aliases, which reveal overlapping subjects to other studies available through dbGaP.
- This subject sample mapping data table includes a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs.
- This sample attributes data table includes body site where sample was collected, analyte type, tumor status, sequencing center, funding source, TOPMed phase, project, and study name.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- The subject consent data table includes subject IDs, consent group information, subject's sex, and subject aliases, which reveal overlapping subjects to other studies available through dbGaP.
- This subject sample mapping data table includes a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs.
- This sample attributes data table includes body site where sample was collected, analyte type, tumor status, sequencing center, funding source, TOPMed phase, project, and study name.
C0680251 (UMLS CUI [1,2])
C2348561 (UMLS CUI [1,2])
C0043210 (UMLS CUI [1,3])
C1696073 (UMLS CUI [1,4])
C0008976 (UMLS CUI [1,5])
C1518527 (UMLS CUI [1,6])
C1512693 (UMLS CUI [1,7])
C1706256 (UMLS CUI [1,8])
C0586888 (UMLS CUI [1,9])
C2713450 (UMLS CUI [1,10])
C3846158 (UMLS CUI [1,11])
C0038454 (UMLS CUI [1,12])
C1861172 (UMLS CUI [1,13])
C2737276 (UMLS CUI [1,14])
C1512693 (UMLS CUI [2,1])
C0009932 (UMLS CUI [2,2])
C0586888 (UMLS CUI [2,3])
C2713450 (UMLS CUI [2,4])
C3846158 (UMLS CUI [2,5])
C0332122 (UMLS CUI [2,6])
C0038454 (UMLS CUI [2,7])
C1861172 (UMLS CUI [2,8])